🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

150,33 USD

Máx. histórico

156,92

10 días

Caída desde máximo

-4,20%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,32%

Cierre anterior

152,34

Rango de hoy

150,09 – 152,22

Volumen hoy

4.298.143

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER
122,22 (puede no estar actualizado)
Dividend yield
2,23% (puede no estar actualizado)
Precio objetivo analistas
148,73 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 2 días
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,24%
Fecha de pago Importe por participación
28/11/1977 0,0113 USD
29/08/1977 0,0099 USD
31/05/1977 0,0099 USD
01/03/1977 0,0099 USD
30/11/1976 0,0099 USD
30/08/1976 0,0093 USD
01/06/1976 0,0093 USD
02/03/1976 0,0093 USD
01/12/1975 0,0093 USD
29/08/1975 0,0093 USD
02/06/1975 0,0093 USD
03/03/1975 0,0093 USD
30/08/1974 0,0093 USD
03/06/1974 0,0093 USD
04/03/1974 0,0093 USD
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
27/12/2019 87,48 87,50 87,09 87,31 +0,18% 0,47% 3.758.966
26/12/2019 87,40 87,52 86,90 87,16 -0,11% 0,71% 3.062.675
24/12/2019 87,44 87,53 86,90 87,25 -0,33% 0,72% 2.343.223
23/12/2019 87,62 87,81 87,25 87,54 +0,17% 0,63% 7.895.946
20/12/2019 87,27 88,40 86,68 87,39 +1,77% 1,97% 17.849.641
19/12/2019 85,77 85,96 85,39 85,87 +0,41% 0,67% 7.602.716
18/12/2019 85,26 85,88 85,05 85,52 +0,67% 0,97% 11.578.199
17/12/2019 85,24 85,35 84,47 84,94 -0,30% 1,04% 11.690.545
16/12/2019 85,54 85,88 85,10 85,20 +0,11% 0,91% 10.355.183
13/12/2019 85,11 85,49 84,39 85,11 -0,42% 1,29% 7.571.800
12/12/2019 84,96 85,84 84,84 85,47 +0,66% 1,18% 6.863.876
11/12/2019 85,06 85,39 84,78 84,90 -0,13% 0,72% 6.821.746
10/12/2019 84,54 85,43 84,46 85,02 +0,43% 1,15% 8.663.711
09/12/2019 84,83 84,92 84,16 84,66 -0,15% 0,90% 8.054.823
06/12/2019 84,92 85,15 84,69 84,78 +0,11% 0,55% 7.245.872
05/12/2019 84,67 84,72 83,94 84,69 +0,09% 0,92% 8.267.462
04/12/2019 83,52 84,67 83,19 84,61 +1,48% 1,77% 7.293.766
03/12/2019 82,71 83,46 82,54 83,38 +0,39% 1,12% 7.466.162
02/12/2019 83,53 83,96 82,59 83,05 -0,16% 1,64% 5.597.997
29/11/2019 83,18 83,75 83,04 83,19 -0,49% 0,85% 4.880.222
27/11/2019 83,40 83,85 83,01 83,60 +0,31% 1,01% 6.037.318
26/11/2019 82,06 83,44 81,98 83,34 +1,91% 1,78% 19.233.420
25/11/2019 82,10 82,62 81,43 81,77 +0,29% 1,45% 9.021.289
22/11/2019 81,73 82,40 81,41 81,54 -0,01% 1,21% 7.800.159
21/11/2019 81,77 81,84 80,41 81,55 +0,22% 1,75% 7.195.568
20/11/2019 80,66 81,56 80,58 81,36 +0,73% 1,22% 8.160.147
19/11/2019 80,53 81,06 80,12 80,77 +0,62% 1,16% 9.691.380
18/11/2019 80,78 80,94 80,01 80,28 -0,91% 1,15% 10.701.757
15/11/2019 80,81 81,68 80,76 81,01 +0,41% 1,13% 9.675.870
14/11/2019 81,03 81,28 79,87 80,68 -0,32% 1,74% 7.911.247